Much of what mesenchymal stem cells do happens through what they release. Learn what the MSC secretome is and why it is central to regenerative medicine.
When researchers describe how mesenchymal stem cells (MSCs) support repair, they often focus on the secretome - the collection of bioactive molecules MSCs release into their surroundings. This concept has changed how scientists view MSC therapy.
The term "secretome" refers to all the soluble factors and vesicles a cell secretes into its environment. For MSCs, this includes proteins, lipids, nucleic acids, and small membrane-bound packages. Together, these components create a biological signal field around each cell. The secretome is dynamic and changes based on tissue context, oxygen, and surrounding cells. It is now considered one of the main ways MSCs influence their environment.
The MSC secretome contains several distinct categories of molecules. Growth factors such as VEGF, HGF, and TGF-beta support tissue repair and blood vessel formation. Cytokines and chemokines influence immune cell behavior and recruit cells to sites of injury. Extracellular vesicles, including exosomes, carry proteins and RNA between cells. This combination allows MSCs to influence multiple repair processes at the same time.
Once released, secretome components interact with native cells in the surrounding tissue. They can encourage resident stem and progenitor cells to participate in repair. They help calm excessive inflammation and shift immune activity toward a healing state. They support the formation of new blood vessels, which improves nutrient delivery to damaged areas. Together, these effects create a microenvironment that is more favorable to regeneration.
For many years, MSCs were thought to repair tissue mainly by transforming into new cells. Current research suggests that paracrine signaling, through the secretome, accounts for much of their effect. This shift in understanding helps explain why MSCs can influence tissues they do not become a part of. It also clarifies why benefits can occur even when relatively few cells reach the injury site. Differentiation still matters for some applications, but it is no longer seen as the only mechanism.
The secretome model influences how MSC therapies are designed and evaluated. Outcomes are increasingly linked to biological activity rather than just cell counts. Conditions involving inflammation, immune imbalance, or microenvironmental damage are common research targets. Examples include joint disease, certain lung conditions, and selected autoimmune disorders. This framework gives a clearer rationale for why MSC therapy is studied across many specialties.
Because much of the benefit comes from secreted factors, researchers are exploring cell-free therapies. These can include conditioned media, purified extracellular vesicles, or specific exosome preparations. Cell-free products may offer easier storage, simpler dosing, and reduced complexity. They are still in earlier research stages compared with established cell-based MSC therapy. Regulatory pathways for these products are evolving as evidence accumulates.
The composition of the secretome depends on the conditions cells experience during expansion. Oxygen levels, culture media, donor age, and tissue source all influence which factors are released. Stress, contamination, or poor processing can shift the secretome in unwanted directions. This is one reason why standardized manufacturing matters in MSC research and therapy. Quality programs increasingly evaluate secretome characteristics as part of product testing.
MSCs do not just repair tissue by becoming new cells - they communicate. The secretome is one of the most important reasons mesenchymal stem cells remain a central focus of regenerative medicine research.